| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +100.00% | +19.64% | -0.94% | +20.59% | +20.03% | — |
| 14d | 4 | +100.00% | +19.42% | -0.55% | +19.98% | +19.13% | — |
| 30d | 4 | +100.00% | +28.45% | +1.79% | +26.66% | +25.36% | — |
| 60d | 4 | +75.00% | +41.37% | +4.46% | +36.91% | +47.20% | — |
| 90d | 4 | +75.00% | +18.71% | +6.36% | +12.36% | +16.66% | — |
| 180d | 4 | +75.00% | -2.50% | +10.80% | -13.30% | -6.58% | — |
| 1y | 4 | +0.00% | -74.33% | +1.06% | -75.39% | -74.19% | — |
| 2y | 4 | +0.00% | -89.72% | +2.36% | -92.09% | -90.63% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 181,818 | $2.75 | $500.0K | 559,203 | Mar 25, 2025 | Mar 27, 2025 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 377,385 | Jan 1, 2024 | Jan 26, 2024 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 362,385 | Dec 1, 2023 | Dec 4, 2023 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 20,000 | — | — | 347,385 | Nov 30, 2023 | Dec 4, 2023 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 225,000 | $8.68 | $1.95M | 327,385 | May 19, 2023 | May 22, 2023 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 351,037 | $8.68 | $3.05M | 351,037 | May 19, 2023 | May 22, 2023 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 430,000 | — | — | 430,000 | Jan 20, 2022 | Jan 24, 2022 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 52,950 | — | — | 52,950 | Jan 3, 2022 | Jan 24, 2022 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 823,170 | $3.28 | $2.70M | 2,047,698 | Jun 3, 2021 | Jun 7, 2021 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 302,000 | $2.43 | $733.9K | 1,224,528 | May 6, 2021 | May 10, 2021 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 398,001 | $2.53 | $1.01M | 922,528 | May 5, 2021 | May 6, 2021 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 300,000 | $2.29 | $687.0K | 524,527 | May 4, 2021 | May 6, 2021 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 153,846 | $2.65 | $407.7K | 153,846 | Mar 31, 2020 | Apr 2, 2020 ↗ | View → |